Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England J.K. Abernethy, A.P. Johnson, R. Guy, N. Hinton, E.A. Sheridan,

Slides:

Advertisements

Similar presentations

Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial P.J. van der Geest, M. Mohseni, D. Nieboer,

Advertisements

Cryptococcosis—the impact of delay to diagnosis

Women with symptoms of a urinary tract infection but a negative urine culture: PCR- based quantification of Escherichia coli suggests infection in most.

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients L. Trovato, P. Betta, M.G.

Estimation of Rickettsia rickettsii copy number in the blood of patients with Rocky Mountain spotted fever suggests cyclic diurnal trends in bacteraemia

The detection of microbial DNA but not cultured bacteria is associated with increased mortality in patients with suspected sepsis—a prospective multi-centre.

Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study E. Munier-Marion, T. Bénet, C. Régis,

Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset S.R. Deeny, E. van Kleef, S. Bou-Antoun,

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications T.-L. Liao, Y.-M.

Migrant health—a cause for concern?

Therapy of acute gastroenteritis: role of antibiotics

Clinical and microbiological outcome in septic patients with extremely low 25- hydroxyvitamin D levels at initiation of critical care G. De Pascale, M.S.

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient P. Helbling Clinical Microbiology.

A. Ignacio, M. R. Fernandes, V. A. A. Rodrigues, F. C. Groppo, A. L

Mcr-1 is borne by highly diverse Escherichia coli isolates since 2004 in food-producing animals in Europe F. El Garch, M. Sauget, D. Hocquet, D. LeChaudee,

Discrepancies between general practitioners' vaccination recommendations for their patients and practices for their children N. Agrinier, M. Le Maréchal,

A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J

V.E. Nambudiri, R.C. Dwyer, C.A. Camargo, T.S. Kupper, D.J. Pallin

Women with symptoms of a urinary tract infection but a negative urine culture: PCR- based quantification of Escherichia coli suggests infection in most.

Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,

M. Nørgaard, H. Larsson, G. Pedersen, H.C. Schønheyder, H.T. Sørensen

First isolation of Akkermansia muciniphila in a blood-culture sample

Escherichia coli native valve endocarditis

Hepatitis C: global epidemiology and strategies for control

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit.

Pharmacodynamics of doxycycline

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts R. Freeman

Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia S.-C. Kuo, Y.-T. Lee,

Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period P. Harris, D.-A. Siew, M. Proud, P. Buettner,

Epidemiology of opportunistic infections in AIDS patients

C. Fabrizio, A. Procopio Clinical Microbiology and Infection

Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit E. Theocharidou, B. Agarwal, G. Jeffrey,

S. David, M. Mentasti, J. Parkhill, V.J. Chalker

Symposia and Oral Presentations

Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England S. Thelwall,

Sexually acquired Zika virus: a systematic review

Systematic review of antibiotic consumption in acute care hospitals

H. M. El Sahly, L.D. Teeter, J.M. Musser, E.A. Graviss

Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia S. Terraneo, M. Ferrer, I. Martín-Loeches,

M. Bassetti, M.P. Molinari, M. Mussap, C. Viscoli, E. Righi

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Comparison of different methods for identification of species of the genus Raoultella: report of 11 cases of Raoultella causing bacteraemia and literature.

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy L. Boglione,

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study J. Smit, L.E. López-Cortés,

C. Gagliotti, L. Nobilio, M.L. Moro

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS M. Rybicka,

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

I. Bitar, A. Piazza Clinical Microbiology and Infection

Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

Antibiotic resistance patterns of more than clinical Escherichia coli isolates in Southeast Austria, 1998–2013 A. Badura, G. Feierl, G. Pregartner,

Clostridium difficile toxin testing by National Health Service (NHS) acute Trusts in England: 2008–2013 S.M. Gerver, A.P. Johnson, R.J. Hope Clinical.

Survival of rhinoviruses on human fingers

R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

J.L. Balcázar Clinical Microbiology and Infection

CMI editorial report, 2016 Clinical Microbiology and Infection

Bloodstream infections as a marker of community-acquired sepsis severity. Results from the Portuguese community-acquired sepsis study (SACiUCI study)

The burden of chikungunya in the Pacific

CMI readers' survey Clinical Microbiology and Infection

Rajko Saletinger, Mario Poljak, Franc Strle

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England J.K. Abernethy, A.P. Johnson, R. Guy, N. Hinton, E.A. Sheridan, R.J. Hope Clinical Microbiology and Infection Volume 21, Issue 3, Pages 251.e1-251.e8 (March 2015) DOI: 10.1016/j.cmi.2015.01.001 Copyright © 2015 Terms and Conditions

Fig. 1 Time to death (all-cause mortality), in days after positive blood culture, in patients who died within 30 days of a blood culture being taken that grew Escherichia coli. Clinical Microbiology and Infection 2015 21, 251.e1-251.e8DOI: (10.1016/j.cmi.2015.01.001) Copyright © 2015 Terms and Conditions

Fig. 2 Time to death (all-cause mortality), in days after positive blood culture, in patients who died within 30 days of a blood culture being taken that grew E. coli in relation to timing of bacteraemia onset. Sixty-nine patients were not admitted but died one or more days after specimen collection. This may be due to many factors such as inaccurate data entry or patients self-discharging after specimen collection. Clinical Microbiology and Infection 2015 21, 251.e1-251.e8DOI: (10.1016/j.cmi.2015.01.001) Copyright © 2015 Terms and Conditions